Project IMPACT: Diabetes

The Background

The Background

Launched in 2010, Project IMPACT: Diabetes is the first national diabetes self-management program conducted by the APhA Foundation in partnership with the Bristol-Myers Squibb Foundation’s Together on Diabetes initiative that is specifically designed to improve the health of underserved populations with limited access to quality care in 25 participating communities disproportionately affected by diabetes.

Today, more than 2,000 patients who are uninsured, under-insured, homeless and/or living below the poverty line are receiving care from community-based interdisciplinary teams that include pharmacists, physicians, diabetes educators and other members of the health care team.

Participating organizations include community and university-affiliated pharmacies, self-insured employers, Federally Qualified Health Centers (FQHCs), free clinics and others that have the opportunity to leverage unique stakeholders, existing programs, creative ideas, and additional resources to effectively adapt and implement similar models of care.  The APhA Foundation provides communities with tools, resources, guidance and support to facilitate local success.

Project IMPACT: Diabetes is modeled after several other highly successful APhA Foundation programs that produced positive clinical, humanistic and economic outcomes, including the Diabetes Ten City Challenge (2005-2009); the Patient Self-Management Program for Diabetes (2003-2005); and the APhA Foundation’s cholesterol management program, Project ImPACT: Hyperlipidemia™ (1996-1999). 

Frequently Asked Questions

Key Objectives

  1. Expand proven community-based models of care to patients who need it the most in communities across the U.S.
  2. Improve key indicators of diabetes care in selected communities
  3. Strengthen local models of care by establishing community peer-to-peer networking and mentoring relationships
  4. Establish a sustainable platform for permanent change by embedding the following guiding principles:
  • Identification and support of disproportionate share populations
  • Implementation of collaborative care programs engaging pharmacists
  • Establishment of continuous quality improvement processes
  • Utilization of patient self-management credentialing
  • Collection and regular reporting of minimum data sets


Advisory Committee

An Advisory Committee of industry leaders provided input and guidance to the project. The group includes representatives from:

  • American Pharmacists Association 
  • Center for Health Value Innovation
  • Giant Food Stores
  • National Diabetes Education Program
  • U.S. Health and Human Resources (HHS) Office of Women’s Health
  • U.S. Health Resource Services Administration – Pharmacy Services Support Center
  • Walgreens

In partnership with: